Documents
Application Sponsors
Marketing Status
Application Products
001 | INJECTABLE;IV (INFUSION) | EQ 40MG BASE/VIAL | 0 | PANTOPRAZOLE SODIUM | PANTOPRAZOLE SODIUM |
FDA Submissions
| ORIG | 1 | AP | 2012-11-08 | |
LABELING; Labeling | SUPPL | 3 | AP | 2021-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2021-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2021-03-17 | STANDARD |
LABELING; Labeling | SUPPL | 6 | AP | 2021-03-17 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 19 |
SUPPL | 3 | Null | 7 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 15 |
SUPPL | 6 | Null | 15 |
TE Codes
CDER Filings
AKORN INC
cder:Array
(
[0] => Array
(
[ApplNo] => 79197
[companyName] => AKORN INC
[docInserts] => ["",""]
[products] => [{"drugName":"PANTOPRAZOLE SODIUM","activeIngredients":"PANTOPRAZOLE SODIUM","strength":"EQ 40MG BASE\/VIAL","dosageForm":"INJECTABLE;IV (INFUSION)","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"PANTOPRAZOLE SODIUM","submission":"PANTOPRAZOLE SODIUM","actionType":"EQ 40MG BASE\/VIAL","submissionClassification":"INJECTABLE;IV (INFUSION)","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)